News Focus
News Focus
icon url

Investor2014

08/26/21 10:53 AM

#327620 RE: k9uwa #327611

Don't disagree that all seems conceivable. We just won't get to market for any of those diseases without completed trials leading to approval.

Perhaps at some point after a few approvals blarcamesine can get a label update that says go ahead try it on any CNS disease and ingrown toe nails.